EE194 Marginal Healthcare Expenditure Burden Among U.S. Civilian Noninstitutionalized Individuals with Chronic Kidney Disease: 2011-2020 von Bhatt, P., Thornton, J.D.

Volltext

Use Of Selective-Serotonin Reuptake Inhibitors And Platelet Aggregation Inhibitors Among Individuals With Co-Occurring Heart Disease And Depression Or Anxiety von Thornton, J.D, Agarwal, P, Sambamoorthi, U

Volltext

Prescription Drug Cost Burden of US Patients with Chronic Kidney Disease: 2011-2020 von Bhatt, P., Thornton, J.D.

Volltext

Change in opioid-related inpatient discharges after the ICD-9 To ICD-10 transition in Texas von Bhatt, P.J., Thornton, J.D.

Volltext

Is Signature Size Associated With Organ Donor Designation on Driver's Licenses? von Sehgal, N.K.R, Sullivan, C, Scallan, C, Figueroa, M, Pencak, J.A, Kirkland, J, Scott, K, Thornton, J.D

Volltext

Stability of Organ Donor Designations on Driver's Licenses von Sehgal, N.K.R, Sullivan, C, Figueroa, M, Pencak, J.A, Thornton, J.D

Volltext

EE382 Healthcare Expenditure Burden of Melanoma in the Era of Immune Checkpoint Inhibitors von Olateju, O., Li, J., Thornton, J.D., Aparasu, R.R.

Volltext

PNS112 PRESCRIPTION DRUG MONITORING PROGRAM QUERYING RATES FOR PRESCRIPTION STIMULANTS von Tata, V., Varisco, T., Thornton, J.D.

Volltext

PMU51 PROVIDER ATTITUDE'S, INTENTION, AND BEHAVIOR TO PRESCRIBE BUPRENORPHINE FOR THE TREATMENT OF OPIOID USE DISORDER: A SYSTEMATIC REVIEW von Bapat, S., Varisco, T., Thornton, J.D.

Volltext

PMH66 THE BURDEN OF COST TO PATIENTS WITH OPIOID USE DISORDER TREATED WITH MEDICATION ASSISTED THERAPY: A SYSTEMATIC SCOPING REVIEW von Anyanwu, P., Obimah, K., Thornton, J.D.

Volltext

PNS172 TRENDS IN PRESCRIPTION MONITORING PROGRAM PATIENT QUERIES AND DELEGATE ACCESS von Fleming, M., Thornton, J.D., Ferries, E.A.

Volltext

First-line Treatment Patterns and Associated Survival Among Older Patients with Advanced Cancer von Olateju, O.A., Mgbere, O.O., Thornton, J.D., Essien, E.J.

Volltext

PMH33 VARIATION IN TREATMENT PERSISTENCE BETWEEN ACUTE AND CHRONIC OPIOID USERS RECEIVING BUPRENORPHINE PRODUCTS FOR OPIOID USE DISORDER von Varisco, T., Thornton, J.D.

Volltext

PND41 HEALTHCARE EXPENDITURE BURDEN IN MULTIPLE SCLEROSIS: MARGINAL COSTS BASED ON NATIONAL LEVEL DATA von Earla, J.R., Thornton, J.D., Hutton, G.J., Aparasu, R.R.

Volltext

TP3 FACTORS ASSOCIATED WITH PRESCRIBING OF ORAL DISEASE MODIFYING AGENTS IN MULTIPLE SCLEROSIS von Earla, J.R., Hutton, G.J., Thornton, J.D., Aparasu, R.R.

Volltext

PDG22 A DECISION ANALYSIS OF ADDING ANGIOTENSIN II TO RENAL REPLACEMENT THERAPY TO TREAT PATIENTS WITH ACUTE KIDNEY INJURY AND VASODILATORY SHOCK von Anyanwu, P., Wanat, M., Thornton, J.D., Sansgiry, S.S.

Volltext

CE2 Effect of Different Variance Estimation Methods with Inverse Probability Treatment Weights (IPTW) on Comparative Effectiveness Measure in Multiple Sclerosis von Earla, J., Hutton, G.J., Thornton, J.D., Chen, H., Johnson, M.L., Aparasu, R.R.

Volltext

PMU42 Inclusion of Background Variables of the Theory of Planned Behavior to Predict Provider Intention to Prescribe Buprenorphine von Bapat, S., Fleming, M., Abughosh, S., Essien, E.J., Washburn, M., Thornton, J.D.

Volltext

Prominent Impact of Community Risk Factors on Kidney Transplant Candidate Processes and Outcomes von Schold, J. D., Heaphy, E. L. G., Buccini, L. D., Poggio, E. D., Srinivas, T. R., Goldfarb, D. A., Flechner, S. M., Rodrigue, J. R., Thornton, J. D., Sehgal, A. R.

Volltext

Physician perspectives on risk mitigation strategies for prescribing opioids: A thematic analysis of a national survey von Tata, V., Al Saadi, R., Cho, S.K., Varisco, T.J., Wanat, M., Thornton, J.D.

Volltext